The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/63894
Quintiles Durham, NC www.quintiles.com (919) 998-2000 Main Service Areas: Bioanalytical, Clinical SERVICES & CAPABILITIES: Bioanalytical laboratories, biostatistics, biosimilars, central laboratories, clinical monitoring, data management, ECG, functional service provider, lifecycle safety, patient and investigator recruitment, medical writing, model-based drug development, regulatory, Quintiles Infosario. THERAPEUTIC AREAS: Cardiovascular, central nervous system, endocrinology, infectious diseases, internal medicine, oncology, pediatrics, public health and government services, translational oncology, vaccines, women's health. KEY INDUSTRY PARTNER: Cenduit TNERS: xxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxxxxxxxxxxxx,xxxxxxxxxxxxxxxxxx "We are honored to be recognized for our leadership in clinical research - which is ultimately about improving human health and saving lives. Quintiles employees worldwide are committed to developing new ways to improve the quality, reliability, and productivity of clinical research, helping speed the approval of new medicines for patients. Together with our customers, we're creating a new model of drug development that leverages expertise and data to make better decisions faster." — Paula Brown Stafford, exec VP, clinical development SCYNEXIS, Inc. Research Triangle Park, NC www.scynexis.com (919) 544-8600 Main Service Areas: Bioanalytical, Preclinical SERVICES & CAPABILITIES: SCYNEXIS delivers efficient and innovative drug discovery and development solutions to our global health and pharmaceutical partners through services that include integrated pharmaceutical solutions, discovery research, and integrated parasitology. THERAPEUTIC AREAS: Anti-parasites, anti-infectives, CNS, ophthalmology, oncology, cardiovascular, and dermatology KEY INDUSTRY PARTNERS: Merial Ltd., Medicines For Malaria Ventures, Drugs For Neglected Diseases initiative, Merck & Co., Mitsubishi Tanabe, Sanofi "SCYNEXIS is recognized for its strict adherence to what we call the 'path to success', which starts with the definition of the customer's Target Product Profile at the start of each project, to define the path forward. We design workflows to meet the goals and define challenges and gaps, and then deploy a team with the right skills to render maximum progress in the project. SCYNEXIS works hard to deliver timely results to our customers." — Dr. Yves Ribeill, president and CEO Seventh Wave Laboratories Chesterfield, MO www.7thwavelabs.com (636) 519-4885 Main Service Areas: Bioanalytical, Preclinical SERVICES & CAPABILITIES: Bioanalysis, preclinical PK/PD/TK studies and analysis, clinical pharmacokinetic/pharmacodynamic data analysis, in vitro ADME, dissolution analysis, pharmacology and disease models, toxicology studies, histology, immunohistochemistry/immunofluorescence, pathology, image analysis, stereology, and preclinical consulting THERAPEUTIC AREAS: We work across multiple therapeutic areas, including endocrinology and metabolic syndrome, cardiovascular, respiratory, inflammation in multiple organ systems, oncology, and neurology in support of a diversity of small organic and biotherapeutic compounds. Key locations: Chesterfield, MO; St. Louis, MO Contact: Jody DeBold info@7thwavelabs.com Key location: Research Triangle Park, NC Contact: Terry Marquardt terry.marquardt@scynexis.com Key locations: China, India, Japan, Singapore, United Kingdom, United States Contact: Robin Wendlandt robin.wendlandt@quintiles.com "We believe in putting the needs of our clients first, and we understand that time is money. Therefore, we respond quickly, and we remain flexible, allowing our clients to customize each project to meet their needs. Our multidisciplinary group of experts joins the sponsor as an extension of their internal team and dedicates themselves to each study as if it was their own." — Dr. John Sagartz, CEO The CRO Leadership Awards 2012 28